Cargando…
Druggable driver gene alterations in redefined large cell carcinoma in Chinese patients: an observational study
BACKGROUND: Few reports have investigated the genetic status of large cell carcinoma (LCC) in Chinese patients under the 2015 World Health Organization (WHO) classification. We aimed to analyze the distribution of druggable driver gene alterations, including mutations in epidermal growth factor rece...
Autores principales: | Yang, Jinhua, Li, Yuping, Ma, Benting, Xie, Huikang, Chen, Linsong, Gao, Xuejuan, He, Wenxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799145/ https://www.ncbi.nlm.nih.gov/pubmed/35117356 http://dx.doi.org/10.21037/tcr-20-1675 |
Ejemplares similares
-
Druggable Drivers of Lung Cancer
por: Fawdar, Shameem, et al.
Publicado: (2013) -
Redefining the modular organization of the core Mediator complex
por: Wang, Xuejuan, et al.
Publicado: (2014) -
Genomic alterations and possible druggable mutations in carcinoma of unknown primary (CUP)
por: Es, Hamidreza Aboulkheyr, et al.
Publicado: (2021) -
Identification of Druggable Cancer Driver Genes Amplified across TCGA Datasets
por: Chen, Ying, et al.
Publicado: (2014) -
The PHLPP2 phosphatase is a druggable driver of prostate cancer progression
por: Nowak, Dawid G., et al.
Publicado: (2019)